Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Magn Reson Med. 2009 Nov;62(5):1112–1119. doi: 10.1002/mrm.22137

Figure 1.

Figure 1

Tumor growth curves for xenograft hormone resistant human prostate cancer CWR22r with bolus 100 mg/kg 17-AAG treatment (n=9) and without the treatment (n=8). Average tumor volumes were 781 ± 202 mm3 at day 14 (treated) and 1493 ± 711 mm3 at day 13(without treatment), with a statistically significant p=0.01.